SCHEMBL6311404

SCHEMBL6311404

CCOC(=O)c1cccc2c1nc1c(C#N)c(C)c(-c3ccccc3)c(N3CCCC3N(C)C)n12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.39
L3MBTL1 Q9Y468 6/20 0.39
KDM4E B2RXH2 7/20 0.39
HPGD P15428 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.38
HSD17B10 Q99714 2/20 0.37
ALOX15 P16050 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PRF1 P14222 3/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
POLB P06746 2/20 0.35
RAB9A P51151 1/20 0.35
RXFP1 Q9HBX9 2/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311055 0.91 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDLMNAMEN1
SCHEMBL6311408 0.86 ALDH1A1 (0.39) ALDH1A1L3MBTL1KDM4EHPGDTDP1
SCHEMBL6312401 0.84 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDLMNAMEN1
SCHEMBL6310096 0.80 SMN1; SMN2 (0.45) ALDH1A1L3MBTL1KDM4EHPGDTDP1
Formic Acid SCHEMBL6310668 0.80 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDTDP1LMNA
SCHEMBL6311871 0.79 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDLMNAMEN1
SCHEMBL6317696 0.78 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDTDP1LMNA
SCHEMBL6320385 0.76 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDTDP1LMNA
SCHEMBL6310580 0.76 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDTDP1LMNA
SCHEMBL6311058 0.76 HRH3 (0.36) ALDH1A1KDM4EHPGDLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 ALDH1A1 2550/4885L3MBTL1 3913/4885KDM4E 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.